Skip to main content
. 2023 Jan 17;47(3):803–811. doi: 10.1007/s00264-023-05695-z

Table 4.

Comparison of patient- and hospital-related data of all matched patients with a new unplanned wound revision depending on the wound dressing

Variable Treatment failures
Wound dressing Total (n = 19) Epi-VAC (n = 12) Control group (n = 7)
Mean age (years) 65.7 ± 13.6 67.2 ± 10.2 63.1 ± 18.7
Body mass index (kg/m2) 30.4 ± 6.9 32.36 ± 6.7 26.93 ± 6.1
Male (%) 63.2 50 85.7
ASA score 2.7 2.7 2.7
Diabetes mellitus (%) 47.4 58.3 28.6
 Insulin-dependent (%) 36.8 50 14.3
 Oral antidiabetics (%) 0 0 0
Pressure ulcer (%) 15.8 25 0
At least one concomitant disease (%) 89.5 100 71.4
Nicotine abuse (%) 21.1 16.7 28.6
Systemic cortisone therapy (%) 5.3 0 14.3
Peripheral arterial disease (PAVD) (%) 5.3 0 14.3
Coronary artery disease (CAD) (%) 15.8 16.7 14.3
Arterial hypertension (%) 84.2 91.7 71.4
COPD (%) 10.5 0 28.6
Active cancer (%) 26.3 16.7 42.9
Osteoporosis (%) 21.1 25 14.3
Renal insufficiency ≥ 3 (%) 31.6 33.3 28.6
Anticoagulation (%) 5.3 25 14.3
Albumin (g/l) 28.8 ± 7.23 28.47 ± 7.77 29.45 ± 6.63
Hemoglobin (mmol/l) 5.79 ± 1.05 5.76 ± 1.03 5.84 ± 1.16
C-reactive protein (mg/l) 161.94 ± 117.18 186.66 ± 128.92 119.56 ± 86.04
Leukocytes (× 109/l) 10.95 ± 3.45 10.9 ± 4.12 11.04 ± 2.13
Number of addressed vertebral bodies (n) 5.6 ± 3.1 5.2 ± 2.7 6.4 ± 3.8
Duration of initial surgery (min) 169.6 ± 65.2 152.8 ± 55.5 203.2 ± 75
Duration of revision surgery (min) 63.6 ± 16.1 60.4 ± 15.8 69 ± 16.5
Time between first and second WR (days) 11.7 ± 7 12 ± 8.1 11.3 ± 5.2
Length of hospital stay (days) 49.9 ± 29.2 51 ± 31.6 48 ± 26.9
ICU admission (%) 47.4 50 42.9
Length of ICU stay (days) 8.8 ± 17.8 11.5 ± 21.9 3.3 ± 1.2
Mortality (%) 10.5 8.3 14.3
Local antibiotic therapy (%) 100 100 100
Germ (%) 78.9 75 85.7
S. epidermidis (%) 21.1 16.7 28.6
S. aureus (%) 42.1 33.3 57.1
Propionibacterium acnes (%) 0 0 0
E. faecalis (%) 10.5 16.7 0
E. coli (%) 10.5 16.7 0
Pseudomonas aeruginosa (%) 0 0 0
Another germ (%) 26.3 25 28.6
Mixed infections (%) 26.3 25 28.6

Data indicated as mean or percentage

PAVD peripheral arterial disease, COPD chronic obstructive pulmonary disease, WR wound revision